Skip to main content

Table 2 Lifetime expected cost per TDT patient at 2018/2019 prices from a societal perspective

From: Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective

Total cost Item US Dollar, USD ($) Malaysia Ringgit,(MYR) Proportion of total (%)
TC2 ICT drug 345,251.68 1,405,174.32 56.9
Blood transfusion 79,407.41 323,188.15 13.1
Routine laboratory and instrumental monitoring test 49,984.71 203,437.75 8.2
IOL Complications 48,838.38 198,772.20 8.1
DFO administration 37,725.72 153,543.67 6.2
TC3 45,457.57 185,012.31 7.5
TC1 (TDT patient lifetime cost) 606,665.46 2,469,128.41 100.0